Baseline demographic, anthropometric, RA-related, CRF and CVD characteristics for the total RA population as well as the exercise and control groups
| Total RA sample (n=36) | Exercise group (n=18) | Control group (n=18) | |
|---|---|---|---|
| Demographic | |||
| Female gender, n (%) | 28 (78%) | 14 (78%) | 14 (78%) |
| Age (years) | 53.9±9.9 | 55.0±9.8 | 52.8±10.1 |
| Anthropometric | |||
| Height (cm) | 165.0±8.7 | 165.3±9.6 | 164.8±7.8 |
| Weight (kg) | 78.3±15.2 | 78.9±17.9 | 77.6±11.9 |
| BMI (kg/m2) | 28.8±5.1 | 28.7±5.1 | 28.8±5.3 |
| Fat mass (%) | 36.6±8.4 | 36.1±8.4 | 37.2±8.7 |
| RA characteristics | |||
| Disease duration (years) | 6.0 (4.0–10.0) | 5.5 (3.0–9.7) | 7.0 (5.0–10.0) |
| DAS 28 | 3.2±1.1 | 3.2±1.2 | 3.2±1.1 |
| HAQ | 1.4±0.8 | 1.4±0.8 | 1.4±0.7 |
| ESR (mm 1st h) | 12.5 (7.2–21.0) | 14.5 (8.0–25.0) | 9.0 (4.2–19.0) |
| CRP (mg/l) | 3.0 (3.0–10.1) | 3.0 (3.0–12.4) | 3.0 (3.0–6.8) |
| CRF | |||
| VO2max (l/min) | 1.82±0.5 | 1.9±0.52 | 1.7±0.5 |
| VO2max (ml/min/kg) | 23.7±6.8 | 24.8±7.6 | 22.4±5.7 |
| Resting HR | 75.1±10.1 | 73.7±11.5 | 76.9±10.3 |
| Maximum HR | 161.0±17.7 | 162.0±18.1 | 160.0±17.7 |
| IPAQ (MET min/week) | 2060 (1272–3394) | 2193(1201–3568) | 1508 (1037–3200) |
| CVD | |||
| Resting systolic BP (mm Hg) | 129.2±13.0 | 131.4±12.3 | 126.7±13.6 |
| Resting diastolic BP (mm Hg) | 76.9±7.6 | 78.4±6.1 | 75.2±8.9 |
| Triglycerides (mmol/l) | 1.5±0.7 | 1.5±0.6 | 1.6±0.9 |
| TC (mmol/l) | 4.9±1.0 | 5.0±1.0 | 4.8±1.0 |
| HDL (mmol/l) | 1.4±0.4 | 1.4±0.4 | 1.5±0.4 |
| TC/HDL | 3.7±1.2 | 3.9±1.1 | 3.5±1.4 |
| Insulin (pmol/l) | 61.2 (30.5–101) | 65 (40.5–95.2) | 49 (21–90.2) |
| HOMA | 2.2±1.5 | 2.5±1.6 | 1.7±1.2 |
| QUICKI | 0.344±0.05 | 0.336±0.05 | 0.360±0.056 |
| 10-year CVD risk (%) | 1.0 (0–4.0) | 1.0 (0–4.0) | 1.0 (0–3.0) |
Results expressed as mean±SD or median (range).
BMI, body mass index; BP, blood pressure; CRF, cardiorespiratory fitness; CRP, C-reactive protein; CVD, cardiovascular disease; DAS, Disease Activity Score; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HDL, high density lipoprotein; HOMA, Homeostasis Model Assessment of Insulin Resistance; HR, heart rate; IPAQ, International Physical Activity Questionnaire; QUICKI, Quantitative Insulin Sensitivity Check Index; RA, rheumatoid arthritis; VO2max, maximal oxygen capacity; TC, total cholesterol.